Covid-19 is now in phase 3 -the community spread phase and infected patients symptomatic as well
as a symptomatic increasing at an exponential phase. The current options for the tests are limited,
lengthy, costly and controlled only by a few pharmaceutical companies. Above all the daily testing
capacity has a limitation with the number keeping on increasing or masses trying to opting for these
tests as a precautionary measure.
In India, the number of cumulative people tested per thousand people is 1.821, which is much less
as compared to even countries like Iceland where the cumulative testing per thousand males is
about 168.75. Thus, we need to elevate our screening procedures so as to identify the individuals
who are affected with COVID-19.
The key to this challenge is to detect the COVID-19 cases using Mass Screening or Testing
Innovations. In this context there is need to have a high scale production system in place. While
engineering firms could consider switching some manufacturing to help ramp production of state of
art equipment’s and technologies, it will still take longer to manufacture. Thus, we are looking for an
existing, proven technology that can be rapidly adapted to be built in locally or at large scale.
Current accepted testing solution includes RT-PCR tests to identify the patients who have acquired
COVID-19 but it has scalability and cost issues. Hence, we need some innovative solution which can
be scaled to large masses.
This report highlights about several Mass Screening and Testing Innovations all round the world. It
mentions several technologies that existed even before this COVID era but are finding vast variety of
applications now along with a variety of emerging technologies that could be worthy enough to
tackle the issues that we are facing.
Original Research Challenge: CLICK HERE (Or https://bit.ly/31Newmq)